Health & Wellbeing

Anti-aging mechanism of calorie restriction identified in Yale study

Anti-aging mechanism of calorie restriction identified in Yale study
New findings indicate long-term calorie restriction inhibits the activity of a protein known to increase inflammation
New findings indicate long-term calorie restriction inhibits the activity of a protein known to increase inflammation
View 1 Image
New findings indicate long-term calorie restriction inhibits the activity of a protein known to increase inflammation
New findings indicate long-term calorie restriction inhibits the activity of a protein known to increase inflammation

Animal studies have consistently demonstrated calorie-controlled diets lead to better health and longer lifespans. Human trials testing different dietary regimes have established calorie restriction as an effective way to lose weight, but it hasn’t been clear if long-term calorie restricted diets generate the same systemic health benefits in humans as seen in animal studies.

This new study, led by scientists at Yale University, offers one of the most robust investigations into the health effects of long-term calorie restricted diets in humans ever conducted. The results have homed in on a protein that seems to play a key role in age-related immune dysfunction and the researchers hypothesize it could be therapeutically targeted to extend lifespan in humans.

The researchers leveraged data from a landmark clinical trial conducted a few years ago called CALERIE (Comprehensive Assessment of Long term Effects of Reducing Intake of Energy). The trial recruited more than 200 healthy non-obese subjects and tasked half with reducing their caloric intake by 25 percent.

The trial ran for two years, allowing for unique insights into the long-term effects of caloric restriction across a number of physiological biomarkers. In the end, the interventional cohort achieved a consistent calorie reduction of 14 percent from their baseline intake at the beginning of the study.

Senior author on the new study, Vishwa Deep Dixit, says this investigation into CALERIE data focused on how long-term calorie restriction in humans influenced immune response and inflammation.

“Because we know that chronic low-grade inflammation in humans is a major trigger of many chronic diseases and, therefore, has a negative effect on life span,” said Dixit. “Here we’re asking: What is calorie restriction doing to the immune and metabolic systems and if it is indeed beneficial, how can we harness the endogenous pathways that mimic its effects in humans?”

The first discovery came when the researchers examined MRI data focused on the thymus gland. The thymus produces immune T-cells and is known to age much more rapidly than other organs in the body. Age-related thymus dysfunction is one of the reasons immune responses in the elderly are weak.

Incredibly, the researchers found two years of calorie restriction seemed to increase the functional volume of the thymus gland compared to data gathered at the beginning of the trial. A reduction in fat around the gland was also detected, compared to little change in the control group with no dietary restriction. Dixit says this indicates the thymus was producing more T-cells after two years of calorie restriction than it was at the beginning of the trial.

“The fact that this organ can be rejuvenated is, in my view, stunning because there is very little evidence of that happening in humans,” said Dixit. “That this is even possible is very exciting.”

Zooming in on gene expression changes in fat tissue, the researchers were most interested in one significant alteration. A gene that codes for a protein known as PLA2G7 was strongly inhibited in the cohort eating a calorie restricted diet for two years.

High circulating volumes of PLA2G7 have long been associated with metabolic and immune diseases, including diabetes, cardiovascular disease and some cancers. But it hasn’t been clear exactly how this protein may be contributing to chronic disease.

Knocking out the PLA2G7 gene in mice led to a number of intriguing effects that resembled what is seen with caloric restriction. The PLA2G7-inhibited mice were somewhat resistant to diet-induced weight gain, displayed less age-related thymus dysfunction, and showed lower levels of circulating pro-inflammatory biomarkers.

“These findings demonstrate that PLA2G7 is one of the drivers of the effects of calorie restriction,” Dixit said. “Identifying these drivers helps us understand how the metabolic system and the immune system talk to each other, which can point us to potential targets that can improve immune function, reduce inflammation, and potentially even enhance healthy lifespan.”

As well as identifying one of the ways calorie restricted diets may improve human health, the really interesting outcome from the findings is a possible new therapeutic target for general age-related health deterioration. Commenting on the new findings, researchers Timothy Rhodes and Rozalyn Anderson said the study sheds light on how fat-derived molecules can broadly modulate general health. And PLA2G7 therapies could hypothetically be developed to slow the pace of age-related metabolic and immune decline.

“Although there has been interest in CR [calorie restriction] as a lifestyle recommendation for humans, the real potential lies in understanding the mechanisms and translating them,” wrote Rhodes and Anderson. “By identifying critical factors and processes that are causal in the beneficial effects of CR, it could be possible to learn what is creating vulnerability and what might be targeted to change the pace of functional decline. Poised at the intersection of metabolism and immunity, PLA2G7 could be a valuable target for correction of immuno-metabolic dysfunction.”

This is certainly not the first time PLA2G7 has come to the attention of scientists. In the early 2000s, researchers discovered a distinct correlation between elevated PLA2G7 levels and atherosclerosis.

A drug to inhibit PLA2G7 production was developed and large-scale clinical trials on patients with acute coronary syndrome were conducted. While the drug, called Darapladib, was found to be safe, it was also found to be ineffective at reducing the risk of heart disease compared to placebo across two Phase 3 trials encompassing over 25,000 subjects.

It is clear there is a long road ahead before this discovery yields any anti-aging therapy. But Dixit is optimistic about his team’s findings, and indicates they inform how caloric restriction can lead to long-term health benefits in humans.

There may be ongoing debate over what kind of diet is best, Dixit says, but the most immediate takeaway is that simply eating less can be enough to generate notable health benefits.

“There’s so much debate about what type of diet is better – low carbohydrates or fat, increased protein, intermittent fasting, etc. – and I think time will tell which of these are important,” Dixit said. “But CALERIE is a very well-controlled study that shows a simple reduction in calories, and no specific diet, has a remarkable effect in terms of biology and shifting the immuno-metabolic state in a direction that’s protective of human health. So from a public health standpoint, I think it gives hope.”

The new study was published in the journal Science.

Source: Yale University

Well apparently everything taught in medical school is NOT written in stone. Interesting improvement in the Thymus gland with caloric restriction. The role of PLA2G7 in the scheme of things has been teased about for about 20 years now, and although it has no effective use as a cardiac drug - maybe inhibitors will have a role in arthritis and other inflammatory diseases. Good write up!
I'm 51 and it feels like many of these development might just work for me someday...